Cargando…

Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes

AIMS/INTRODUCTION: Genetic and epigenetic mechanisms have been implicated in the pathogenesis of type 1 diabetes, and histone acetylation is an epigenetic modification pattern that activates gene transcription. However, the genome‐wide histone H3 acetylation in new‐onset type 1 diabetes patients has...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanfei, Hou, Can, Wisler, Jonathan, Singh, Kanhaiya, Wu, Chao, Xie, Zhiguo, Lu, Qianjin, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319479/
https://www.ncbi.nlm.nih.gov/pubmed/29791073
http://dx.doi.org/10.1111/jdi.12867
_version_ 1783385067413831680
author Wang, Yanfei
Hou, Can
Wisler, Jonathan
Singh, Kanhaiya
Wu, Chao
Xie, Zhiguo
Lu, Qianjin
Zhou, Zhiguang
author_facet Wang, Yanfei
Hou, Can
Wisler, Jonathan
Singh, Kanhaiya
Wu, Chao
Xie, Zhiguo
Lu, Qianjin
Zhou, Zhiguang
author_sort Wang, Yanfei
collection PubMed
description AIMS/INTRODUCTION: Genetic and epigenetic mechanisms have been implicated in the pathogenesis of type 1 diabetes, and histone acetylation is an epigenetic modification pattern that activates gene transcription. However, the genome‐wide histone H3 acetylation in new‐onset type 1 diabetes patients has not been well described. Accordingly, we aimed to unveil the genome‐wide promoter acetylation profile in CD4(+) T lymphocytes from type 1 diabetes patients, especially for those who are glutamate decarboxylase antibody‐positive. MATERIALS AND METHODS: A total of 12 patients with new‐onset type 1 diabetes who were glutamate decarboxylase antibody‐positive were enrolled, and 12 healthy individuals were recruited as controls. The global histone H3 acetylation level of CD4(+) T lymphocytes from peripheral blood was detected by western blot, with chromatin immunoprecipitation linked to microarrays to characterize the promoter acetylation profile. Furthermore, we validated the results of particular genes from chromatin immunoprecipitation linked to microarrays by using chromatin immunoprecipitation quantitative polymerase chain reaction, and analyzed the transcription level by real‐time quantitative polymerase chain reaction. RESULTS: Elevated global histone H3 acetylation level was observed in type 1 diabetes patients, with 607 differentially acetylated genes identified between type 1 diabetes patients and controls by chromatin immunoprecipitation linked to microarrays. The hyperacetylated genes were enriched in biological processes involved in immune cell activation and inflammatory response. Gene‐specific assessments showed that increased transcription of inducible T‐cell costimulator was in concordance with the elevated acetylation in its gene promoter, along with positive correlation with glutamate decarboxylase antibody titer in type 1 diabetes patients. CONCLUSIONS: The present study generates a genome‐wide histone acetylation profile specific to CD4(+) T lymphocytes in type 1 diabetes patients who are glutamic acid decarboxylase antibody‐positive, which is instrumental in improving our understanding of the epigenetic involvement in autoimmune diabetes.
format Online
Article
Text
id pubmed-6319479
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63194792019-01-08 Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes Wang, Yanfei Hou, Can Wisler, Jonathan Singh, Kanhaiya Wu, Chao Xie, Zhiguo Lu, Qianjin Zhou, Zhiguang J Diabetes Investig Articles AIMS/INTRODUCTION: Genetic and epigenetic mechanisms have been implicated in the pathogenesis of type 1 diabetes, and histone acetylation is an epigenetic modification pattern that activates gene transcription. However, the genome‐wide histone H3 acetylation in new‐onset type 1 diabetes patients has not been well described. Accordingly, we aimed to unveil the genome‐wide promoter acetylation profile in CD4(+) T lymphocytes from type 1 diabetes patients, especially for those who are glutamate decarboxylase antibody‐positive. MATERIALS AND METHODS: A total of 12 patients with new‐onset type 1 diabetes who were glutamate decarboxylase antibody‐positive were enrolled, and 12 healthy individuals were recruited as controls. The global histone H3 acetylation level of CD4(+) T lymphocytes from peripheral blood was detected by western blot, with chromatin immunoprecipitation linked to microarrays to characterize the promoter acetylation profile. Furthermore, we validated the results of particular genes from chromatin immunoprecipitation linked to microarrays by using chromatin immunoprecipitation quantitative polymerase chain reaction, and analyzed the transcription level by real‐time quantitative polymerase chain reaction. RESULTS: Elevated global histone H3 acetylation level was observed in type 1 diabetes patients, with 607 differentially acetylated genes identified between type 1 diabetes patients and controls by chromatin immunoprecipitation linked to microarrays. The hyperacetylated genes were enriched in biological processes involved in immune cell activation and inflammatory response. Gene‐specific assessments showed that increased transcription of inducible T‐cell costimulator was in concordance with the elevated acetylation in its gene promoter, along with positive correlation with glutamate decarboxylase antibody titer in type 1 diabetes patients. CONCLUSIONS: The present study generates a genome‐wide histone acetylation profile specific to CD4(+) T lymphocytes in type 1 diabetes patients who are glutamic acid decarboxylase antibody‐positive, which is instrumental in improving our understanding of the epigenetic involvement in autoimmune diabetes. John Wiley and Sons Inc. 2018-06-26 2019-01 /pmc/articles/PMC6319479/ /pubmed/29791073 http://dx.doi.org/10.1111/jdi.12867 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Articles
Wang, Yanfei
Hou, Can
Wisler, Jonathan
Singh, Kanhaiya
Wu, Chao
Xie, Zhiguo
Lu, Qianjin
Zhou, Zhiguang
Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title_full Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title_fullStr Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title_full_unstemmed Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title_short Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
title_sort elevated histone h3 acetylation is associated with genes involved in t lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319479/
https://www.ncbi.nlm.nih.gov/pubmed/29791073
http://dx.doi.org/10.1111/jdi.12867
work_keys_str_mv AT wangyanfei elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT houcan elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT wislerjonathan elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT singhkanhaiya elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT wuchao elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT xiezhiguo elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT luqianjin elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes
AT zhouzhiguang elevatedhistoneh3acetylationisassociatedwithgenesinvolvedintlymphocyteactivationandglutamatedecarboxylaseantibodyproductioninpatientswithtype1diabetes